November 1996: The FDA allows clearance for Boston Scientifics’ new product called ProteGen. This is a process that will allow devices to go onto the market without a clinical testing, as long as the manufacturer can prove that it is similar to a previous device.  ProteGen was the first transvaginal mash device used to treat incontinence. June … [Read more...]